EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cellular origin and characterization of autoantibodies against type I IFNs in COVID-19 and APS-1

Rui Sun, Siyu Lin, Luca Simonelli, Benedikt Strunz, Anish Behere, Mattia Pedotti, Tian Xu, Fanglei Zuo, Likun Du, Hui Wan, Sara Lestani, Leire de Campos-Mata, Stelios Vlachiotis, Dorottya Kalmár, Anders Sönnerborg, Dorota Religa, Susanna Brighenti, Benedict J. Chambers, Martin Cornillet, Angelica Cuapio, Malin Flodström-Tullberg, Nicole Marquardt, Jagadeeswara Rao Muvva, Anna Norrby-Teglund, Johan K. Sandberg, David Wullimann, Isabel Diaz Lozano, Kristoffer Strålin, Soo Aleman, Hans-Gustaf Ljunggren, Antonio Piralla, Fausto Baldanti, Olle Kämpe, Sophie Bensing, Lennart Hammarström, Nils Landegren, Zexian Zeng, Niklas K. Björkström, Luca Varani, Harold Marcotte

Journal of Experimental Medicine · 2026-11-02 · 223 (12)

DOI: 10.1084/jem.20260268 ↗
AbstractBibliografische Angaben

Abstract

Autoantibodies against type I IFNs can severely compromise antiviral defense, yet the mechanisms underlying their development remain elusive. Using high-throughput autoantigen profiling, we observed that a subgroup of severe COVID-19 patients exhibited strong binding to multiple type I IFNs. Integrated single-cell RNA and B cell receptor (BCR) sequencing with functional analysis identified B cell subsets/states enriched for IFN-α2–binding and –neutralizing antibodies in COVID-19. These findings were compared with those from patients with autoimmune polyendocrine syndrome type I, a rare genetic disease characterized by defective immune tolerance and persistent type I IFN autoimmunity. Competition surface plasmon resonance and AlphaFold 3 structural modeling identified three major functional epitope groups and seven predicted structural subclasses among neutralizing antibodies. Our results indicate that IFN-α2 autoreactivity is present in both naive and antigen-experienced B cell compartments, whereas functional IFN-neutralizing antibodies are predominantly associated with memory and atypical B cells, consistent with defective tolerance and affinity maturation-mediated selection of autoreactive B cell clones.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →